Brightspring Health Services Inc

BTSG remains in a Stage 2 advancing uptrend with healthy higher highs and higher lows. After a recent pullback into rising EMAs, price found support and displayed a reversal signal, suggesting the continuation of the advance. With long-term trend intact, supportive volume dynamics, and no active bearish patterns, the current pullback presents a buying opportunity near EMAs.

• ↑Q1 2026 revenue reached $3.6 B, up 26% YoY
• ↑Adjusted EBITDA rose 45% YoY to $190 M
• ↓P/E ratio of 50.7x implies premium valuation risk